AU2021264554B2 - Compounds and methods for prevention and treatment of coronavirus infections - Google Patents
Compounds and methods for prevention and treatment of coronavirus infectionsInfo
- Publication number
- AU2021264554B2 AU2021264554B2 AU2021264554A AU2021264554A AU2021264554B2 AU 2021264554 B2 AU2021264554 B2 AU 2021264554B2 AU 2021264554 A AU2021264554 A AU 2021264554A AU 2021264554 A AU2021264554 A AU 2021264554A AU 2021264554 B2 AU2021264554 B2 AU 2021264554B2
- Authority
- AU
- Australia
- Prior art keywords
- 3clpro
- sars
- cov
- acid
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018690P | 2020-05-01 | 2020-05-01 | |
| US63/018,690 | 2020-05-01 | ||
| PCT/US2021/029840 WO2021222534A1 (en) | 2020-05-01 | 2021-04-29 | Compounds and methods for prevention and treatment of coronavirus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021264554A1 AU2021264554A1 (en) | 2023-01-05 |
| AU2021264554B2 true AU2021264554B2 (en) | 2026-05-21 |
Family
ID=78292168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021264554A Active AU2021264554B2 (en) | 2020-05-01 | 2021-04-29 | Compounds and methods for prevention and treatment of coronavirus infections |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12433901B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142713A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7805010B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116568295B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021264554B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202206080A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222534A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021311814A1 (en) * | 2020-07-23 | 2023-03-02 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
| WO2023065223A1 (zh) * | 2021-10-21 | 2023-04-27 | 北京大学深圳研究生院 | 鱼针草酸在制备抑制新型冠状病毒与变异株的感染与复制的医药组合物中的用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100210869A1 (en) * | 2009-02-13 | 2010-08-19 | Kaohsiung Medical University | Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof |
| US20140105928A1 (en) * | 2004-01-06 | 2014-04-17 | Paul Edward Stamets | Antiviral and antibacterial activity from medicinal mushrooms |
| WO2020176436A1 (en) * | 2019-02-25 | 2020-09-03 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2481489A1 (en) * | 2002-11-29 | 2004-06-17 | Morinaga Milk Industry Co., Ltd. | Cysteine protease inhibitor |
| US7919665B2 (en) | 2009-02-17 | 2011-04-05 | Conocophillips Company | Mercury removal from hydrocarbons |
| TW201231474A (en) * | 2011-01-26 | 2012-08-01 | Univ Kaohsiung Medical | Triterpenoid composition of Antrodia cinnamomea, preparation and analysis method thereof |
| FI126047B (en) * | 2012-08-28 | 2016-06-15 | John Eriksson | Pharmaceutical compositions of anisomelic acid and their use |
| TWI453026B (zh) * | 2013-05-14 | 2014-09-21 | Jenisa Biotechnology Corp Ltd | 魚針草萃取物及其純化物抗流感病毒之用途 |
| US9645651B2 (en) | 2013-09-24 | 2017-05-09 | Microsoft Technology Licensing, Llc | Presentation of a control interface on a touch-enabled device based on a motion or absence thereof |
| US11779620B2 (en) * | 2020-04-03 | 2023-10-10 | Turtle Bear Holdings, Llc | Combined fungal composition for modulating inflammatory response |
| CN113521060B (zh) * | 2020-04-17 | 2022-12-06 | 北京大学深圳研究生院 | 鱼针草内酯抗新型冠状病毒的用途 |
| WO2021218974A1 (en) * | 2020-04-28 | 2021-11-04 | Alps Biotech Co., Ltd. | Uses of antrodia cinnamomea extract in manufacturing products for reducing expression and treating associated diseases of angiotensin converting enzyme 2 |
-
2021
- 2021-04-29 CN CN202180046668.8A patent/CN116568295B/zh active Active
- 2021-04-29 JP JP2022566726A patent/JP7805010B2/ja active Active
- 2021-04-29 WO PCT/US2021/029840 patent/WO2021222534A1/en not_active Ceased
- 2021-04-29 AU AU2021264554A patent/AU2021264554B2/en active Active
- 2021-04-29 EP EP21795939.4A patent/EP4142713A1/en not_active Withdrawn
- 2021-04-30 US US17/245,828 patent/US12433901B2/en active Active
- 2021-05-03 TW TW110115949A patent/TW202206080A/zh unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140105928A1 (en) * | 2004-01-06 | 2014-04-17 | Paul Edward Stamets | Antiviral and antibacterial activity from medicinal mushrooms |
| US20100210869A1 (en) * | 2009-02-13 | 2010-08-19 | Kaohsiung Medical University | Ethanol extract of antrodia camphorata for inducing apoptosis and preparation method thereof |
| WO2020176436A1 (en) * | 2019-02-25 | 2020-09-03 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
Non-Patent Citations (1)
| Title |
|---|
| WU CANRONG, et al: "Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods", ACTA PHARMACEUTICA SINICA B, vol. 10, no. 5, (2020), pages 766 - 788, DOI: 10.1016/j.apsb.2020.02.008 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202206080A (zh) | 2022-02-16 |
| US20210338690A1 (en) | 2021-11-04 |
| CN116568295A (zh) | 2023-08-08 |
| AU2021264554A1 (en) | 2023-01-05 |
| US12433901B2 (en) | 2025-10-07 |
| CN116568295B (zh) | 2026-02-13 |
| WO2021222534A1 (en) | 2021-11-04 |
| EP4142713A1 (en) | 2023-03-08 |
| JP2023524274A (ja) | 2023-06-09 |
| JP7805010B2 (ja) | 2026-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | SARS-CoV-2: structure, biology, and structure-based therapeutics development | |
| Haque et al. | A comprehensive review about SARS-CoV-2 | |
| Xu et al. | Broad spectrum antiviral agent niclosamide and its therapeutic potential | |
| Kuo et al. | Kinetic characterization and inhibitor screening for the proteases leading to identification of drugs against SARS-CoV-2 | |
| CN113289018B (zh) | 金诺芬等老药及其组合物在抗单正链rna病毒中的应用 | |
| WO2021205296A1 (en) | Method of treating covid-19 | |
| KR20220146558A (ko) | 항-코로나바이러스에서의 디설피람의 용도 | |
| Ghosh et al. | Progress in anti-SARS coronavirus chemistry, biology and chemotherapy | |
| CN113262224A (zh) | 奈非那韦在制备防治新冠肺炎药物中的应用 | |
| Kumar et al. | A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing | |
| US12433901B2 (en) | Compounds and methods for prevention and treatment of coronavirus infections | |
| KR20230011972A (ko) | 코로나바이러스로 인한 질병을 치료 및/또는 예방하는 화합물 및 이의 용도 | |
| Kooshkaki et al. | Coronavirus disease 2019: a brief review of the clinical manifestations and pathogenesis to the novel management approaches and treatments | |
| JP7856325B2 (ja) | ウイルス感染を予防および処置するための化合物および方法 | |
| Singh et al. | COVID-19: pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies | |
| CN113893345A (zh) | 247种化合物及其组合物在抗新型冠状病毒感染中的应用 | |
| CN113440527B (zh) | 萘酚喹或含萘酚喹的组合制剂在抗冠状病毒中的应用 | |
| US11986478B2 (en) | Targeting papain-like protease for broad-spectrum coronaviruses inhibition | |
| US20230310369A1 (en) | Method and composition for inhibiting virus infection | |
| US20250214981A1 (en) | Compound and application thereof in preparation of medicine for treating enterovirus-related diseases | |
| RU2829731C1 (ru) | Применение дисульфирама при резистентности коронавируса | |
| Bajpai et al. | The Biogenesis, Transmission, Structural and Therapeutics on SARS-CoV-2 (COVID-19) Pandemic: Challenges and Global Perspective. Research & Reviews: A Journal of Immunology. 2021; 11 (1): 8–23p | |
| Barile et al. | Therapeutic targeting of coronavirus spike glycoprotein priming | |
| CN100478030C (zh) | 抗传染性非典型性肺炎药物作用靶标及其预防和治疗药物 | |
| CN113893347A (zh) | 1869种化合物及其组合物在抗新型冠状病毒感染中的应用 |